BioCentury | Nov 19, 2020
Emerging Company Profile

Umoja launches with $53M round to test cell therapy cocktails that expand CAR T cells within patients

...to treat solid tumors or hematologic malignancies.Named for a Swahili word that translates to “unity,” Umoja Biopharma Inc....
...Andy ScharenbergPatents: Undisclosed number of issued patents covering main technology platformsTARGETSIL-2 – Interleukin-2IL-15 – Interleukin-15 Paul Bonanos Umoja Biopharma Inc. CAR...
Items per page:
1 - 1 of 1
BioCentury | Nov 19, 2020
Emerging Company Profile

Umoja launches with $53M round to test cell therapy cocktails that expand CAR T cells within patients

...to treat solid tumors or hematologic malignancies.Named for a Swahili word that translates to “unity,” Umoja Biopharma Inc....
...Andy ScharenbergPatents: Undisclosed number of issued patents covering main technology platformsTARGETSIL-2 – Interleukin-2IL-15 – Interleukin-15 Paul Bonanos Umoja Biopharma Inc. CAR...
Items per page:
1 - 1 of 1